BRIEF-RedHill Biopharma receives FDA Orphan Drug Designation for MESUPRON for pancreatic cancer By: Reuters: Company News October 20, 2017 at 07:39 AM EDT * RedHill Biopharma receives FDA Orphan Drug Designation for MESUPRON for pancreatic cancer Read More >>